In vivo MR spectroscopic imaging of the adrenal glands: distinction between adenomas and carcinomas larger than 15 mm based on lipid content

Service des Radio-Isotopes, Hopital Cochin, Paris, France.

The usefulness of MR spectroscopic imaging for discriminating between lipid and water was applied to the in vivo differentiation of adrenal adenomas from carcinomas. By using the Dixon sequence in 20 patients, the lipid content of 22 adrenal tumors larger than 15 mm was determined. The mean percentage of lipid in 15 adenomas was 13.4% (standard deviation, 8%), compared with 3.5% lipid (standard deviation, 2%) in seven carcinomas. Only one lesion would have been misclassified on the basis of in vivo measurements of lipid content. After surgery, in vitro MR spectroscopy was used to determine the percentage of lipid in excised samples of nine of the 22 tumors. These in vitro measurements confirmed the in vivo results on lesions larger than 20 mm in diameter. Respiratory artifacts appeared to decrease the accuracy of in vivo measurements in smaller lesions. In vivo MR spectroscopic imaging of adrenal tumors appears to be useful for differentiating between adrenal carcinomas and adenomas.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. F. Faria, S. M. Goldman, J. Szejnfeld, H. Melo, C. Kater, P. Kenney, M. P. Huayllas, G. Demarchi, V. V. Francisco, C. Andreoni, et al. Adrenal Masses: Characterization with in Vivo Proton MR Spectroscopy Initial Experience Radiology, December 1, 2007; 245(3): 788 - 797. [Abstract] [Full Text] [PDF]

				G. Savci, Z. Yazici, N. Sahin, S. Akgoz, and E. Tuncel Value of Chemical Shift Subtraction MRI in Characterization of Adrenal Masses Am. J. Roentgenol., January 1, 2006; 186(1): 130 - 135. [Abstract] [Full Text] [PDF]

				H. K. Hussain, T. L. Chenevert, F. J. Londy, V. Gulani, S. D. Swanson, B. J. McKenna, H. D. Appelman, S. Adusumilli, J. K. Greenson, and H. S. Conjeevaram Hepatic Fat Fraction: MR Imaging for Quantitative Measurement and Display--Early Experience Radiology, December 1, 2005; 237(3): 1048 - 1055. [Abstract] [Full Text] [PDF]

				F. Fujiyoshi, M. Nakajo, Y. Fukukura, and S. Tsuchimochi Characterization of Adrenal Tumors by Chemical Shift Fast Low-Angle Shot MR Imaging: Comparison of Four Methods of Quantitative Evaluation Am. J. Roentgenol., June 1, 2003; 180(6): 1649 - 1657. [Abstract] [Full Text] [PDF]

				L. Yao, T. Namimoto, Y. Yamashita, K. Mitsuzaki, Y. Nakayama, O. Makita, M. Katoda, and M. Takahashi Routine Opposed-Phase FLASH MR Imaging Does Not Quantify Fat Content Drs Namimoto and colleagues respond: Radiology, October 1, 2001; 221(1): 274 - 274. [Full Text] [PDF]

				T. Namimoto, Y. Yamashita, K. Mitsuzaki, Y. Nakayama, O. Makita, M. Kadota, and M. Takahashi Adrenal Masses: Quantification of Fat Content with Double-Echo Chemical Shift In-Phase and Opposed-Phase FLASH MR Images for Differentiation of Adrenal Adenomas Radiology, March 1, 2001; 218(3): 642 - 646. [Abstract] [Full Text]

				M. N. Hood, V. B. Ho, J. G. Smirniotopoulos, and J. Szumowski Chemical Shift: The Artifact and Clinical Tool Revisited RadioGraphics, March 1, 1999; 19(2): 357 - 371. [Abstract] [Full Text] [PDF]

				D. G. Mitchell Evaluating the impact of magnetic resonance imaging on patients with operable non-small-cell lung cancer and unilateral adrenal masses: Importance of appropriate technique J. Thorac. Cardiovasc. Surg., April 1, 1995; 109(4): 814 - 815. [Full Text]